Synopsis
Synopsis
0
USDMF
0
CEP/COS
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. Astomin
2. At 17
3. D-3-methyl-n-methylmorphinan
4. Dastosin
5. Dimemorfan
6. Dimemorfan Phosphate (1:1) Salt
7. Dimemorfan, (9alpha,13alpha,14alpha)-isomer
8. Dinemorphan
1. 36304-84-4
2. Astomin
3. Dimemorfan Phosphate [jan]
4. S203y5y1qp
5. Dimemorfan (phosphate)
6. (1s,9s,10s)-4,17-dimethyl-17-azatetracyclo[7.5.3.01,10.02,7]heptadeca-2(7),3,5-triene;phosphoric Acid
7. 3,17-dimethylmorphinan
8. Gentus
9. At-17 Phosphate
10. Unii-s203y5y1qp
11. Einecs 252-958-6
12. D-3-methyl-n-methylmorphinan Phosphate
13. Ncgc00182065-02
14. Dsstox_cid_28649
15. Dsstox_rid_82919
16. Dsstox_gsid_48723
17. Schembl355270
18. Chembl3188434
19. Dtxsid4048723
20. Dimemorfan Phosphate [mi]
21. 3,17-dimethyl-9-alpha,13-alpha,14-alpha-morphinan Phosphate
22. (9-alpha,13-alpha,14-alpha)-3,17-dimethylmorphinan Phosphate
23. Hy-b2215
24. Tox21_113138
25. (9alpha,13alpha,14alpha)-3,17-dimethylmorphinan Dihydrogen Phosphate
26. Dimemorfan Phosphate [mart.]
27. S5280
28. Dimemorfan Phosphate [who-dd]
29. Akos015994725
30. Ccg-268065
31. Cs-7664
32. Ks-1259
33. 3,17-dimethylmorphinan Phosphate
34. Cas-36304-84-4
35. Morphinan, 3,17-dimethyl-, Phosphate (1:1)
36. Q27288466
37. Morphinan, 3,17-dimethyl-, (9-alpha,13-alpha,14-alpha)-, Phosphate (1:1)
Molecular Weight | 353.4 g/mol |
---|---|
Molecular Formula | C18H28NO4P |
Hydrogen Bond Donor Count | 3 |
Hydrogen Bond Acceptor Count | 5 |
Rotatable Bond Count | 0 |
Exact Mass | 353.17559537 g/mol |
Monoisotopic Mass | 353.17559537 g/mol |
Topological Polar Surface Area | 81 Ų |
Heavy Atom Count | 24 |
Formal Charge | 0 |
Complexity | 401 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 3 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 2 |
Antitussive Agents
Agents that suppress cough. They act centrally on the medullary cough center. EXPECTORANTS, also used in the treatment of cough, act locally. (See all compounds classified as Antitussive Agents.)
API Imports and Exports
Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
---|
Upgrade, download data, analyse, strategize, subscribe with us
ABOUT THIS PAGE
93
PharmaCompass offers a list of Dimemorfanphosphate API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Dimemorfanphosphate manufacturer or Dimemorfanphosphate supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Dimemorfanphosphate manufacturer or Dimemorfanphosphate supplier.
PharmaCompass also assists you with knowing the Dimemorfanphosphate API Price utilized in the formulation of products. Dimemorfanphosphate API Price is not always fixed or binding as the Dimemorfanphosphate Price is obtained through a variety of data sources. The Dimemorfanphosphate Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Dimemorfanphosphate manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Dimemorfanphosphate, including repackagers and relabelers. The FDA regulates Dimemorfanphosphate manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Dimemorfanphosphate API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Dimemorfanphosphate supplier is an individual or a company that provides Dimemorfanphosphate active pharmaceutical ingredient (API) or Dimemorfanphosphate finished formulations upon request. The Dimemorfanphosphate suppliers may include Dimemorfanphosphate API manufacturers, exporters, distributors and traders.
click here to find a list of Dimemorfanphosphate suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The Dimemorfanphosphate Drug Master File in Japan (Dimemorfanphosphate JDMF) empowers Dimemorfanphosphate API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the Dimemorfanphosphate JDMF during the approval evaluation for pharmaceutical products. At the time of Dimemorfanphosphate JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of Dimemorfanphosphate suppliers with JDMF on PharmaCompass.
Dimemorfanphosphate Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Dimemorfanphosphate GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Dimemorfanphosphate GMP manufacturer or Dimemorfanphosphate GMP API supplier for your needs.
A Dimemorfanphosphate CoA (Certificate of Analysis) is a formal document that attests to Dimemorfanphosphate's compliance with Dimemorfanphosphate specifications and serves as a tool for batch-level quality control.
Dimemorfanphosphate CoA mostly includes findings from lab analyses of a specific batch. For each Dimemorfanphosphate CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Dimemorfanphosphate may be tested according to a variety of international standards, such as European Pharmacopoeia (Dimemorfanphosphate EP), Dimemorfanphosphate JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Dimemorfanphosphate USP).